| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft Rejection | 39 | 2024 | 4499 | 2.710 |
Why?
|
| Vascular Endothelial Growth Factor A | 25 | 2016 | 3513 | 1.670 |
Why?
|
| Heart Transplantation | 16 | 2018 | 3310 | 1.450 |
Why?
|
| Endothelium, Vascular | 19 | 2010 | 4427 | 0.950 |
Why?
|
| Skin Transplantation | 7 | 2018 | 1098 | 0.950 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2021 | 4405 | 0.900 |
Why?
|
| Kidney Transplantation | 17 | 2024 | 4270 | 0.830 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2022 | 2056 | 0.780 |
Why?
|
| Endothelial Cells | 10 | 2021 | 3584 | 0.750 |
Why?
|
| Transplantation, Homologous | 20 | 2018 | 4860 | 0.720 |
Why?
|
| Receptors, CXCR3 | 8 | 2012 | 240 | 0.710 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2013 | 548 | 0.630 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2016 | 657 | 0.600 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2015 | 2453 | 0.590 |
Why?
|
| Transplantation | 1 | 2019 | 222 | 0.580 |
Why?
|
| Neovascularization, Pathologic | 9 | 2015 | 2631 | 0.560 |
Why?
|
| Signal Transduction | 23 | 2019 | 23601 | 0.530 |
Why?
|
| CD40 Ligand | 10 | 2008 | 528 | 0.520 |
Why?
|
| Receptors, Chemokine | 5 | 2007 | 651 | 0.510 |
Why?
|
| Interferon-gamma | 6 | 2011 | 3160 | 0.510 |
Why?
|
| Chemokines, CXC | 4 | 2006 | 416 | 0.500 |
Why?
|
| Forkhead Transcription Factors | 4 | 2018 | 1624 | 0.490 |
Why?
|
| T-Lymphocytes | 15 | 2021 | 10261 | 0.490 |
Why?
|
| Neovascularization, Physiologic | 3 | 2012 | 1375 | 0.470 |
Why?
|
| Transcriptional Activation | 4 | 2012 | 1744 | 0.460 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 752 | 0.460 |
Why?
|
| Sirolimus | 9 | 2022 | 1545 | 0.450 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2022 | 2880 | 0.450 |
Why?
|
| Cells, Cultured | 20 | 2021 | 18973 | 0.440 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 565 | 0.430 |
Why?
|
| Immunosuppressive Agents | 10 | 2015 | 4209 | 0.420 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2018 | 3111 | 0.410 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2013 | 254 | 0.410 |
Why?
|
| Cell Adhesion Molecules | 6 | 2013 | 1612 | 0.400 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2013 | 124 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 4348 | 0.400 |
Why?
|
| Multiprotein Complexes | 4 | 2015 | 1107 | 0.390 |
Why?
|
| Organ Transplantation | 4 | 2022 | 1174 | 0.390 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2012 | 59 | 0.380 |
Why?
|
| Cell Movement | 9 | 2018 | 5194 | 0.370 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2012 | 1811 | 0.360 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2019 | 2900 | 0.360 |
Why?
|
| Kidney Glomerulus | 3 | 2012 | 568 | 0.360 |
Why?
|
| Lymphokines | 3 | 2003 | 911 | 0.360 |
Why?
|
| Protein Kinases | 2 | 2008 | 1611 | 0.360 |
Why?
|
| Cell Proliferation | 7 | 2019 | 10429 | 0.360 |
Why?
|
| Microvessels | 1 | 2015 | 591 | 0.350 |
Why?
|
| Chemokine CXCL10 | 7 | 2015 | 310 | 0.340 |
Why?
|
| Mice, SCID | 8 | 2016 | 2630 | 0.340 |
Why?
|
| Graft Survival | 9 | 2024 | 3890 | 0.300 |
Why?
|
| Postoperative Complications | 5 | 2016 | 15747 | 0.300 |
Why?
|
| Inflammation | 8 | 2013 | 10850 | 0.290 |
Why?
|
| Chemokines | 6 | 2013 | 956 | 0.290 |
Why?
|
| Immune Tolerance | 1 | 2017 | 2324 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 6220 | 0.290 |
Why?
|
| Hypertension, Renovascular | 1 | 2007 | 113 | 0.280 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 2817 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 634 | 0.270 |
Why?
|
| Animals | 45 | 2022 | 168764 | 0.270 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3251 | 0.270 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 2024 | 0.270 |
Why?
|
| Lymphocyte Activation | 7 | 2015 | 5501 | 0.270 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 680 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2796 | 0.260 |
Why?
|
| Mitochondria | 1 | 2019 | 3673 | 0.260 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2007 | 221 | 0.250 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 2699 | 0.250 |
Why?
|
| Cyclosporine | 5 | 2019 | 778 | 0.250 |
Why?
|
| Monocytes | 5 | 2003 | 2595 | 0.240 |
Why?
|
| Transplantation Tolerance | 2 | 2018 | 640 | 0.240 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 602 | 0.230 |
Why?
|
| Mice | 30 | 2022 | 81819 | 0.230 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 5 | 2000 | 694 | 0.230 |
Why?
|
| Kidney | 4 | 2015 | 7066 | 0.230 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1159 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2018 | 2878 | 0.230 |
Why?
|
| Cell Communication | 5 | 2013 | 1660 | 0.230 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 503 | 0.220 |
Why?
|
| Sesquiterpenes | 1 | 2004 | 175 | 0.220 |
Why?
|
| Coronary Disease | 2 | 2016 | 5912 | 0.220 |
Why?
|
| Erythropoietin | 1 | 2007 | 716 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 5 | 2012 | 5786 | 0.210 |
Why?
|
| Immunologic Memory | 1 | 2009 | 1375 | 0.210 |
Why?
|
| Peritoneal Dialysis | 1 | 2004 | 161 | 0.210 |
Why?
|
| Leukocytes | 6 | 2006 | 2027 | 0.200 |
Why?
|
| Isoantigens | 3 | 2001 | 562 | 0.200 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 11888 | 0.200 |
Why?
|
| Heart | 1 | 2015 | 4414 | 0.200 |
Why?
|
| Intercellular Adhesion Molecule-1 | 6 | 1995 | 1132 | 0.190 |
Why?
|
| Mevalonic Acid | 1 | 2021 | 45 | 0.190 |
Why?
|
| CHO Cells | 2 | 2019 | 1372 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 22332 | 0.190 |
Why?
|
| Humans | 85 | 2024 | 765968 | 0.180 |
Why?
|
| Histocompatibility Antigens | 2 | 2002 | 477 | 0.180 |
Why?
|
| Cricetinae | 2 | 2019 | 2411 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 2476 | 0.180 |
Why?
|
| Membrane Glycoproteins | 4 | 1999 | 3690 | 0.170 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 827 | 0.170 |
Why?
|
| Fibroadenoma | 1 | 2000 | 40 | 0.170 |
Why?
|
| Endothelium | 4 | 1999 | 767 | 0.170 |
Why?
|
| Mycophenolic Acid | 1 | 2002 | 346 | 0.170 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2000 | 101 | 0.170 |
Why?
|
| Telepathology | 1 | 2000 | 77 | 0.160 |
Why?
|
| CpG Islands | 1 | 2004 | 1207 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1657 | 0.160 |
Why?
|
| RNA, Messenger | 10 | 2015 | 12768 | 0.160 |
Why?
|
| Flow Cytometry | 4 | 2016 | 5881 | 0.160 |
Why?
|
| Simvastatin | 1 | 2021 | 345 | 0.160 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6547 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 722 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2009 | 561 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2018 | 8278 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2016 | 5020 | 0.150 |
Why?
|
| Complement C5a | 2 | 2018 | 98 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2007 | 1311 | 0.150 |
Why?
|
| Microfluidic Analytical Techniques | 4 | 2018 | 788 | 0.150 |
Why?
|
| Apoptosis | 7 | 2022 | 9514 | 0.140 |
Why?
|
| Cricetulus | 1 | 2019 | 805 | 0.140 |
Why?
|
| Tacrolimus | 2 | 2019 | 753 | 0.140 |
Why?
|
| Mice, Inbred C3H | 1 | 2018 | 914 | 0.140 |
Why?
|
| Interleukin-8 | 3 | 2018 | 700 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 754 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2005 | 2968 | 0.130 |
Why?
|
| Hyperplasia | 1 | 2000 | 1144 | 0.130 |
Why?
|
| Transplantation Immunology | 1 | 1999 | 541 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 3 | 2004 | 2495 | 0.130 |
Why?
|
| Myocardium | 4 | 2013 | 4760 | 0.130 |
Why?
|
| Umbilical Veins | 4 | 2006 | 421 | 0.120 |
Why?
|
| Jurkat Cells | 2 | 2009 | 737 | 0.120 |
Why?
|
| Methylation | 1 | 2018 | 1073 | 0.120 |
Why?
|
| Neuropilin-2 | 1 | 2015 | 55 | 0.120 |
Why?
|
| L-Selectin | 2 | 2011 | 212 | 0.120 |
Why?
|
| Primary Graft Dysfunction | 1 | 2016 | 112 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2098 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2015 | 9347 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2000 | 1628 | 0.120 |
Why?
|
| Cadherins | 1 | 2019 | 900 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2004 | 2056 | 0.120 |
Why?
|
| Ammonia | 1 | 2015 | 244 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2004 | 1799 | 0.110 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2007 | 386 | 0.110 |
Why?
|
| Microfluidics | 2 | 2018 | 651 | 0.110 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 455 | 0.110 |
Why?
|
| Time Factors | 7 | 2015 | 40065 | 0.110 |
Why?
|
| Isoantibodies | 1 | 2018 | 681 | 0.110 |
Why?
|
| Kidney Neoplasms | 3 | 2022 | 4274 | 0.110 |
Why?
|
| Luciferases | 2 | 2013 | 713 | 0.110 |
Why?
|
| Biopsy | 6 | 2024 | 6763 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14448 | 0.110 |
Why?
|
| Child | 17 | 2024 | 80564 | 0.110 |
Why?
|
| E-Selectin | 5 | 2006 | 576 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2015 | 203 | 0.110 |
Why?
|
| P-Selectin | 1 | 1995 | 597 | 0.100 |
Why?
|
| Child, Preschool | 12 | 2018 | 42500 | 0.100 |
Why?
|
| Antigens | 2 | 2015 | 1438 | 0.100 |
Why?
|
| Chemokine CXCL11 | 1 | 2012 | 43 | 0.100 |
Why?
|
| Interleukin-12 | 3 | 2001 | 579 | 0.100 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2015 | 263 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2018 | 1339 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 3421 | 0.100 |
Why?
|
| Receptors, CXCR | 1 | 2012 | 52 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 11840 | 0.100 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 118 | 0.100 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 339 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 474 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 674 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2008 | 12131 | 0.090 |
Why?
|
| Protein Binding | 4 | 2015 | 9296 | 0.090 |
Why?
|
| Benzodioxoles | 1 | 2012 | 80 | 0.090 |
Why?
|
| Receptors, CCR4 | 1 | 2011 | 75 | 0.090 |
Why?
|
| Glomerulonephritis | 1 | 1993 | 332 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 1884 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15398 | 0.090 |
Why?
|
| Calcineurin | 2 | 2009 | 233 | 0.090 |
Why?
|
| Chemotaxis | 2 | 2014 | 596 | 0.090 |
Why?
|
| Foreskin | 1 | 2010 | 33 | 0.090 |
Why?
|
| Tissue Donors | 2 | 2018 | 2395 | 0.090 |
Why?
|
| Models, Immunological | 2 | 2003 | 517 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1995 | 1090 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 3 | 2007 | 364 | 0.090 |
Why?
|
| Transplants | 1 | 2012 | 208 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4562 | 0.080 |
Why?
|
| Male | 21 | 2019 | 363698 | 0.080 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 669 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2004 | 7599 | 0.080 |
Why?
|
| src-Family Kinases | 1 | 2012 | 538 | 0.080 |
Why?
|
| Lung | 1 | 2007 | 10033 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2015 | 18293 | 0.080 |
Why?
|
| Reperfusion Injury | 2 | 2006 | 1042 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2015 | 7851 | 0.080 |
Why?
|
| Microcirculation | 2 | 2007 | 1280 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 1992 | 1162 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3620 | 0.080 |
Why?
|
| Podocytes | 1 | 2012 | 391 | 0.070 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2007 | 58 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 728 | 0.070 |
Why?
|
| Polyradiculoneuropathy | 1 | 1987 | 65 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 2394 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9550 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1599 | 0.070 |
Why?
|
| Stem Cells | 2 | 2013 | 3540 | 0.070 |
Why?
|
| Cholesterol | 1 | 2016 | 2898 | 0.070 |
Why?
|
| Models, Biological | 5 | 2015 | 9443 | 0.070 |
Why?
|
| Oxygen | 1 | 2018 | 4241 | 0.070 |
Why?
|
| Neutrophils | 2 | 2018 | 3776 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2001 | 962 | 0.070 |
Why?
|
| Glucose | 1 | 2018 | 4335 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2018 | 218 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2001 | 1336 | 0.060 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 6544 | 0.060 |
Why?
|
| Adolescent | 11 | 2018 | 88835 | 0.060 |
Why?
|
| Biological Transport | 1 | 2010 | 2081 | 0.060 |
Why?
|
| Quinazolines | 1 | 2012 | 1364 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 16721 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 1992 | 2216 | 0.060 |
Why?
|
| Nephritis | 1 | 2006 | 146 | 0.060 |
Why?
|
| Liver Circulation | 1 | 2005 | 163 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1999 | 1441 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2008 | 1107 | 0.060 |
Why?
|
| Cytokines | 6 | 2006 | 7421 | 0.060 |
Why?
|
| Regeneration | 1 | 2013 | 1517 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 1 | 2004 | 175 | 0.060 |
Why?
|
| Infant | 8 | 2018 | 36386 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2573 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 3273 | 0.060 |
Why?
|
| ras Proteins | 1 | 2009 | 1053 | 0.060 |
Why?
|
| Cyclohexanes | 1 | 2004 | 151 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4260 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2007 | 1965 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 295 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2004 | 360 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3946 | 0.050 |
Why?
|
| Heart Diseases | 2 | 2015 | 2821 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5753 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 822 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2009 | 3618 | 0.050 |
Why?
|
| Graft vs Host Reaction | 1 | 2003 | 100 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4642 | 0.050 |
Why?
|
| Biological Availability | 1 | 2004 | 385 | 0.050 |
Why?
|
| Gene Expression | 2 | 2011 | 7584 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 6309 | 0.050 |
Why?
|
| Mammals | 1 | 2008 | 1125 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2627 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2003 | 117 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2004 | 1167 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 2086 | 0.050 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2004 | 184 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4392 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1718 | 0.050 |
Why?
|
| Drug Costs | 1 | 2010 | 1193 | 0.050 |
Why?
|
| Research Design | 1 | 2018 | 6209 | 0.050 |
Why?
|
| Antibodies | 1 | 2010 | 2417 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 17075 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12509 | 0.050 |
Why?
|
| Ischemia | 2 | 2007 | 1909 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 1997 | 1701 | 0.050 |
Why?
|
| Trachea | 1 | 2007 | 1085 | 0.050 |
Why?
|
| Lignans | 1 | 2022 | 82 | 0.050 |
Why?
|
| RNA Interference | 1 | 2010 | 2832 | 0.050 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2001 | 29 | 0.050 |
Why?
|
| Syndrome | 1 | 2007 | 3271 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 594 | 0.050 |
Why?
|
| Homeostasis | 1 | 2012 | 3336 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 715 | 0.050 |
Why?
|
| Immunohistochemistry | 5 | 2005 | 11022 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 204 | 0.040 |
Why?
|
| Female | 16 | 2018 | 396112 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2001 | 511 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2018 | 26346 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 561 | 0.040 |
Why?
|
| Acute Disease | 4 | 2005 | 7232 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2446 | 0.040 |
Why?
|
| Placebos | 1 | 2004 | 1659 | 0.040 |
Why?
|
| Adult | 9 | 2015 | 223044 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 308 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1157 | 0.040 |
Why?
|
| Epithelial Cells | 3 | 2007 | 3681 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 2233 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3785 | 0.040 |
Why?
|
| Risk Factors | 5 | 2018 | 74840 | 0.040 |
Why?
|
| Solubility | 1 | 2000 | 1078 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1999 | 241 | 0.040 |
Why?
|
| Living Donors | 2 | 2000 | 645 | 0.040 |
Why?
|
| Skin | 3 | 2000 | 4489 | 0.040 |
Why?
|
| Creatinine | 1 | 2024 | 1915 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2010 | 2192 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2006 | 1761 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1134 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2008 | 4159 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 1999 | 180 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2018 | 54802 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2005 | 2485 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2004 | 1069 | 0.040 |
Why?
|
| Chemotactic Factors | 1 | 2018 | 195 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2006 | 21056 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2006 | 1303 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3430 | 0.030 |
Why?
|
| Haplorhini | 1 | 1998 | 520 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 2002 | 638 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 1999 | 178 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2022 | 1019 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 1560 | 0.030 |
Why?
|
| Macrophages | 3 | 2006 | 5772 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4850 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2002 | 1250 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2001 | 963 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2018 | 726 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2004 | 4015 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2001 | 751 | 0.030 |
Why?
|
| Headache | 1 | 2004 | 1259 | 0.030 |
Why?
|
| Antigens, CD | 2 | 1999 | 4025 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1243 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2001 | 995 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4913 | 0.030 |
Why?
|
| Abscess | 1 | 1999 | 606 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2015 | 65188 | 0.030 |
Why?
|
| Middle Aged | 7 | 2015 | 223009 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2001 | 804 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2000 | 633 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 8611 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 698 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22223 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 213 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1996 | 444 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 2014 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3596 | 0.030 |
Why?
|
| Rats | 4 | 2006 | 23707 | 0.030 |
Why?
|
| Neoplasms | 4 | 2018 | 22340 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2005 | 2747 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1351 | 0.030 |
Why?
|
| Transfection | 3 | 2007 | 5743 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1885 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 295 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 5995 | 0.030 |
Why?
|
| Observer Variation | 1 | 2000 | 2615 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2001 | 9249 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2002 | 2143 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 281 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 1240 | 0.030 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 1992 | 64 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11499 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1992 | 41 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 4353 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 1857 | 0.020 |
Why?
|
| Immunity | 1 | 2018 | 1002 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 790 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 14751 | 0.020 |
Why?
|
| Prognosis | 3 | 2018 | 29922 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39193 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 318 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3211 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2003 | 26318 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 281 | 0.020 |
Why?
|
| Cell Line | 2 | 2003 | 15543 | 0.020 |
Why?
|
| Papio | 1 | 1992 | 671 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1992 | 453 | 0.020 |
Why?
|
| Diastole | 1 | 1993 | 785 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10070 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7478 | 0.020 |
Why?
|
| Sinusitis | 1 | 1999 | 995 | 0.020 |
Why?
|
| Age Factors | 2 | 2004 | 18380 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12437 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 59889 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 4958 | 0.020 |
Why?
|
| Liver | 1 | 2005 | 7562 | 0.020 |
Why?
|
| raf Kinases | 1 | 2009 | 116 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1885 | 0.020 |
Why?
|
| Ion Channels | 1 | 1994 | 1045 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 6364 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 381 | 0.020 |
Why?
|
| Urochordata | 1 | 1988 | 19 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 894 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 1216 | 0.020 |
Why?
|
| Cadaver | 1 | 1992 | 1359 | 0.020 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2010 | 347 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1531 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1994 | 1154 | 0.020 |
Why?
|
| Actins | 1 | 2015 | 2056 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2412 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2007 | 105 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1992 | 1816 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9601 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1993 | 3089 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2009 | 465 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2006 | 206 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1808 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2005 | 47 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 6274 | 0.020 |
Why?
|
| Disease Progression | 2 | 2016 | 13632 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3081 | 0.020 |
Why?
|
| Reference Values | 1 | 1993 | 4908 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1602 | 0.010 |
Why?
|
| Collagen | 1 | 1993 | 2618 | 0.010 |
Why?
|
| Rabbits | 2 | 2006 | 4734 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 610 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2016 | 4493 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 1995 | 2128 | 0.010 |
Why?
|
| Ultrasonography | 2 | 1999 | 5993 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2004 | 95 | 0.010 |
Why?
|
| Genes, ras | 1 | 2006 | 658 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1995 | 3454 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2002 | 24282 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1992 | 1880 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 768 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2844 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1202 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1770 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2927 | 0.010 |
Why?
|
| Edema | 1 | 2006 | 760 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12795 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4893 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 20124 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 2570 | 0.010 |
Why?
|
| Hybridomas | 1 | 1982 | 442 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2007 | 81514 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 1167 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 1039 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8041 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1982 | 852 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9525 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2006 | 920 | 0.010 |
Why?
|
| Aging | 1 | 2018 | 8731 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2006 | 1083 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1410 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4475 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8923 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1995 | 4697 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 3737 | 0.010 |
Why?
|
| Wound Healing | 1 | 2008 | 2792 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 2140 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11641 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2717 | 0.010 |
Why?
|
| Recurrence | 1 | 1987 | 8501 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3432 | 0.010 |
Why?
|
| Bufonidae | 1 | 1994 | 12 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 59489 | 0.010 |
Why?
|
| Dermatitis | 1 | 1996 | 199 | 0.010 |
Why?
|
| Informed Consent | 1 | 2000 | 1010 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 315 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 4528 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1993 | 98 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1993 | 167 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1994 | 2163 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 1724 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 6322 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1992 | 386 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2001 | 1940 | 0.010 |
Why?
|
| Cause of Death | 1 | 2001 | 3708 | 0.010 |
Why?
|
| Appendicitis | 1 | 1996 | 679 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 2406 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5783 | 0.010 |
Why?
|
| Epithelium | 1 | 1993 | 1599 | 0.000 |
Why?
|
| Health Status | 1 | 2000 | 4080 | 0.000 |
Why?
|
| Prednisone | 1 | 1992 | 1565 | 0.000 |
Why?
|
| Aged | 1 | 2000 | 171117 | 0.000 |
Why?
|
| Mental Health | 1 | 2000 | 3278 | 0.000 |
Why?
|
| Comorbidity | 1 | 2001 | 10563 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1994 | 3634 | 0.000 |
Why?
|
| Registries | 1 | 2000 | 8297 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12976 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 2395 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7425 | 0.000 |
Why?
|
| Secretory Rate | 1 | 1982 | 82 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1996 | 4778 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 12403 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8102 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1996 | 3733 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 17594 | 0.000 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1982 | 545 | 0.000 |
Why?
|
| Genes | 1 | 1982 | 1825 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20659 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1982 | 4618 | 0.000 |
Why?
|